Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Cancer Immunol Res. 2016 Dec 30;5(2):118–126. doi: 10.1158/2326-6066.CIR-16-0148

Table 2.

Summary of Cell Density Measurements

Cell density Total (N = 29)
Mean, cells/mm2; median, cells/mm2 (range)
Primary (n = 12)
Mean, cells/mm2; median, cells/mm2 (range)
Metastatic (n =17)
Mean, cells/mm2; median, cells/mm2 (range)
Significance between primary and metastatic (P)
CD8 (invasive margin) 107.9; 44.1 (0–730) 73.0; 9.9 (0–730) 132.5; 100.3 (23.1–357.1) 0.0003
PD-1 (invasive margin) 82.5; 48.9 (1.8–361.6) 41.6; 8.9 (1.8–293.2) 111.3; 83.4 (16.2–361.6) 0.002
PD-L1 (invasive margin) 174.2; 113.9 (0–1035) 80.0; 5.7 (0–862.8) 240.6; 194.5 (15.8–1035) 0.0003
CD8 (intratumor) 53.4; 15.0 (1.3–414.3) 26.2; 8.1 (2.2–204.7) 72.6; 36.9 (1.3–414.3) 0.11
PD-1 (intratumor) 36.9; 11.1 (1.1–309) 24.8; 5.3 (1.1–182.9) 45.5; 20.9 (1.5–309) 0.08
PD-L1 (intratumor) 173.3; 24.3 (1.5–1940) 171.3; 5.6 (1.5–1940) 174.7; 53.7 (1.6–1177) 0.006
NY-ESO-1 5024; 5334 (566–9170) 4682; 5050 (566–8693) 5265; 5920 (946–9170) 0.44